BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

6 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel Coronavirus Main Protease Di- and Tripeptide Inhibitors for Treating COVID-19.EBI
Experimental Drug Development Centre
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir.EBI
Experimental Drug Development Centre
Oral Nonpeptidic, Noncovalent Triazine Coronavirus Main Protease Inhibitors for Treating COVID-19.EBI
Experimental Drug Development Centre
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors.EBI
Experimental Drug Development Centre
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.EBI
Experimental Drug Development Centre
Substituted pyrimidines as cyclin-dependent kinase inhibitorsBDB
Shanghai Pharmaceuticals Holding